Biotech Stocks Featured 5 Biotech Penny Stocks To Watch In September 2020 Which Biotech Penny Stocks Are Trending Right Now? September 8, 20206 minute read
Featured Psychedelic Stocks Top Mushroom Penny Stocks To Watch In September 2020 Should Mushroom Stocks Be Part Of Your Strategy In 2020? September 3, 20205 minute read
Penny Stock News Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… September 2, 20204 minute read
Biotech Stocks Featured 4 Coronavirus Penny Stocks To Watch For September 2020 Are Coronavirus Penny Stocks On Your List This Month? September 1, 20206 minute read
Penny Stock News Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19 TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… August 31, 20206 minute read
Featured Penny Stocks Watch List 3 Penny Stocks To Watch As Health Care Sector Surges These Penny Stocks Have Experienced A Strong Uptrend Recently August 26, 20205 minute read
Penny Stock News Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19 Revive to also explore FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19 August 26, 20206 minute read
Biotech Stocks Featured Penny Stocks Watch List Are These Coronavirus Penny Stocks On Your List Right Now? 3 Coronavirus Penny Stocks To Watch Before September We’re winding down another… August 24, 20205 minute read
Penny Stock News Revive Therapeutics to Expand Phase 3 Clinical Trial for Bucillamine in COVID-19 in Asia-Pacific and Canada TORONTO, Aug. 19, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… August 19, 20206 minute read
Penny Stock News Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19 TORONTO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… August 14, 20204 minute read